Entero Regains Nasdaq Compliance With Grid AI Acquisition
BCC
0.7900
The Fort Worth Press - Entero Regains Nasdaq Compliance With Grid AI Acquisition
USD
-
AED 3.672498
AFN 63.000153
ALL 83.141978
AMD 376.485471
ANG 1.790083
AOA 917.000319
ARS 1368.006
AUD 1.45314
AWG 1.8025
AZN 1.700487
BAM 1.694558
BBD 2.010968
BDT 122.511751
BGN 1.709309
BHD 0.377004
BIF 2965.773868
BMD 1
BND 1.283101
BOB 6.914956
BRL 5.276697
BSD 0.998423
BTN 94.09624
BWP 13.729041
BYN 2.998376
BYR 19600
BZD 2.008109
CAD 1.38685
CDF 2285.499887
CHF 0.79772
CLF 0.023589
CLP 931.560016
CNY 6.91145
CNH 6.921963
COP 3689.46
CRC 462.899991
CUC 1
CUP 26.5
CVE 95.540739
CZK 21.33335
DJF 177.799726
DKK 6.495865
DOP 60.195193
DZD 133.15778
EGP 52.800598
ERN 15
ETB 154.307745
EUR 0.86936
FJD 2.257403
FKP 0.749063
GBP 0.753115
GEL 2.694963
GGP 0.749063
GHS 10.916401
GIP 0.749063
GMD 73.495771
GNF 8752.907745
GTQ 7.638886
GYD 208.893799
HKD 7.833495
HNL 26.511932
HRK 6.546603
HTG 130.753836
HUF 339.36101
IDR 16982
ILS 3.153401
IMP 0.749063
INR 94.77175
IQD 1307.999879
IRR 1313299.999846
ISK 124.660495
JEP 0.749063
JMD 156.917785
JOD 0.708972
JPY 159.849027
KES 129.907037
KGS 87.450232
KHR 3998.336553
KMF 427.000249
KPW 900.088302
KRW 1511.930155
KWD 0.30794
KYD 0.832088
KZT 480.998402
LAK 21565.798992
LBP 89410.383591
LKR 314.008846
LRD 183.234482
LSL 17.08101
LTL 2.95274
LVL 0.60489
LYD 6.375734
MAD 9.322411
MDL 17.537157
MGA 4161.215702
MKD 53.550332
MMK 2102.538494
MNT 3579.989157
MOP 8.045798
MRU 39.8269
MUR 46.770519
MVR 15.460236
MWK 1731.28406
MXN 18.05755
MYR 4.013006
MZN 63.909775
NAD 17.080862
NGN 1383.230512
NIO 36.742473
NOK 9.714203
NPR 150.534765
NZD 1.738295
OMR 0.384496
PAB 0.998471
PEN 3.455542
PGK 4.314509
PHP 60.534019
PKR 278.731944
PLN 3.72784
PYG 6536.015664
QAR 3.640948
RON 4.432101
RSD 102.102971
RUB 81.673918
RWF 1458.028296
SAR 3.752552
SBD 8.041975
SCR 13.467171
SDG 600.999975
SEK 9.449904
SGD 1.28793
SHP 0.750259
SLE 24.550303
SLL 20969.510825
SOS 570.594376
SRD 37.561976
STD 20697.981008
STN 21.225996
SVC 8.73675
SYP 110.526284
SZL 17.078983
THB 32.929501
TJS 9.556146
TMT 3.51
TND 2.938146
TOP 2.40776
TRY 44.458798
TTD 6.776842
TWD 31.972497
TZS 2576.486977
UAH 43.811372
UGX 3714.470144
UYU 40.481936
UZS 12161.933849
VES 466.018145
VND 26337.5
VUV 119.707184
WST 2.754834
XAF 568.30701
XAG 0.014772
XAU 0.000226
XCD 2.70255
XCG 1.799507
XDR 0.706792
XOF 568.311934
XPF 103.329218
YER 238.650219
ZAR 17.21025
ZMK 9001.196166
ZMW 18.745993
ZWL 321.999592
- Lebanon at risk of 'humanitarian catastrophe': UN
- Russia labels 'Mr Nobody Against Putin' teacher a 'foreign agent'
- Belgian diplomat appeals to avoid trial over Congo leader's murder
- Whale filmed giving birth, with a little help from her friends
- France calls Olympic gender test 'step backwards', other countries back policy
- France calls Olympic gender test 'a step backwards', other countries approve
- E-commerce in the crosshairs at WTO in digital taxes battle
- Volkswagen in talks with defence firms on use of Germany plant: CEO
- Oil climbs, stocks fall as markets see no end to war
- Lebanon at real risk of 'humanitarian catastrophe': UN
Entero Regains Nasdaq Compliance With Grid AI Acquisition
BOCA RATON, FL / ACCESS Newswire / October 30, 2025 / Entero Therapeutics, Inc. ("Entero" or the "Company") (NASDAQ:ENTO) is pleased to announce that, as a result of the acquisition of 100% of Grid AI Corp. ("Grid AI"), it has regained compliance with Nasdaq Listing Rule 5550(b)(1) (the "Equity Rule").
Entero's publicly‑listed platform now sits at the intersection of AI, data centers, power grids, and global infrastructure. The acquisition of Grid AI, now operating as a wholly‑owned subsidiary of Entero, enables the Company to participate in one of the most significant secular growth arenas of the coming decade: hyperscale data centers, grid‑edge orchestration, and AI‑driven infrastructure optimization.
Forward‑Looking Statements
This press release contains forward‑looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including statements regarding the strategic benefits of the acquisition, the integration of Grid AI, the ability to maintain compliance with Nasdaq's listing criteria in connection with the Grid AI acquisition and otherwise, the ability to obtain shareholder approval of the common stock underlying the preferred stock issued in the Grid AI acquisition, expected future operating results, market opportunities, and the Company's growth strategy. Actual results may differ materially due to risks and uncertainties. The Company undertakes no obligation to update forward‑looking statements except as required by law.
About Entero Therapeutics, Inc.
Entero Therapeutics (NASDAQ:ENTO) is a publicly listed company. The Company's programs address significant unmet needs in gastrointestinal (GI) health and comprise development of Adrulipase, a recombinant lipase enzyme designed to enable the digestion of fats and other nutrients in cystic fibrosis and chronic pancreatitis patients with exocrine pancreatic insufficiency. Following the acquisition of Grid AI, the Company is continuing these prior operations and is also repositioning into the infrastructure, AI and data‑centre orchestration space. Entero operates Grid AI as a wholly‑owned subsidiary and intends to leverage its public‑market listing and corporate resources to scale the new venture.
About Grid AI
Grid AI is an AI‑driven, grid‑edge software and device orchestration platform enabling business, utility, and hyperscaler customers to forecast, optimize, and dispatch flexible demand, DERs and compute assets. The platform supports major ML frameworks, offers rapid scale across cloud GPU/CPU infrastructure, and is designed to deliver SaaS‑like recurring revenue.
Investor & Media Contacts:
Entero Investor Relations
[email protected]
SOURCE: Entero Therapeutics, Inc.
View the original press release on ACCESS Newswire
L.Holland--TFWP
